DOD
Search
Discussions
Biomedical Jobmarket
News
DOD Alert
Edit DOD
 
ACCOUNT
Login
Register
Forgotten Password?
 
 
Tailored Immunosuppression and Steroid Withdrawal in Pancreas-Kidney Transplantation
 
Diabetes OD > Diabetic Complications > Renal > Transplantation > Kidney-Pancreas Transplantation > Journal Article

(Journal Article): Tailored Immunosuppression and Steroid Withdrawal in Pancreas-Kidney Transplantation
 
Rossetti M, Piccoli GB, Burdese M, Guarena C, Giraudi R, Mezza E, Consiglio V, Soragna G, Messina M, Segoloni GP (Chair of Nephrology, Department of Internal Medicine, University of Turin, Corso Bramante 86-88, 10126 Torino, Italy, giorgina.piccoli(at)unito.it )
 
IN: Rev Diabetic Stud 2004; 1(3):129-136
Impact Factor(s) of Rev Diabetic Stud: 0.125 (2006)

Fulltext:    HTML  PDF

ABSTRACT: BACKGROUND: Recent improvements in simultaneous pancreas-kidney transplantation (SPK) and the striking decrease in acute rejection lead us to focus on the effects of long-term immunosuppression. AIM OF THIS STUDY: Evaluation of a policy of steroid withdrawal and tailored immunosuppression in pancreas-kidney patients treated in a single center. METHODS: review of the clinical charts in 9 SPK recipients (male/female = 5/4, median age 41 years, median follow-up 42 months), by the same operator, under supervision of the two usual caregivers. Therapeutic protocols. Induction phase: all patients received mycophenolate mophetil (starting dose: 2 grams), tacrolimus and steroids, 8 received Simulect, 1 received thymoglobulins. Maintenance therapy was slowly reduced, with the goal of steroid withdrawal. RESULTS: The therapeutic adjustments were mainly determined by two almost opposing elements: 1. Rapid adjustments in the case of side-effects (gastrointestinal problems, infections and neoplasia); 2. Slow tapering off in the case of good organ function. On the other hand, a switch to cyclosporine A and to rapamycine was considered in the case of chronic organ malfunction. By these means, over a median of 42 months follow-up, steroid withdrawal was slowly obtained in 6/9 patients (at a median time of 25 months). CONCLUSIONS: Within the limits of this small-scale study, a tailored immunosuppressive policy allows at least some "positively selected" patients to reach the "dream" of steroid withdrawal after SPK.

TYPE OF PUBLICATION: Original article

REFERENCES:

  1. Becker BN, Odorico JS, Becker YT, Groshek M, Werwinski C, Pirsch JD, Sollinger HW. Simultaneous pancreas-kidney and pancreas transplantation. J Am Soc Nephrol 2001. 12:2517-2527.
  2. Mohan P, Safi K, Little DM, Donohoe J, Conlon P, Walshe JJ, O'Kelly P, Thompson CJ, Hickey DP. Improved patient survival in recipients of simultaneous pancreas-kidney transplant compared with kidney transplant alone in patients with type 1 diabetes mellitus and end-stage renal disease. Br J Surg 2003. 90:1137-1141.
  3. Wynn JJ, Distant DA, Pirsch JD, Norman D, Gaber AO, Ashby VB, Leichtman AB. Kidney and pancreas transplantation. Am J Transplant 2004. 4(Suppl 9):72-80.
  4. Freise CE, Kang SM, Feng S, Posselt A, Hirose K, Hirose R, Stock P. Experience with steroid-free maintenance immunosuppression in simultaneous pancreas-kidney transplantation. Transplant Proc 2004. 36:1067-1068.
  5. Stratta RJ, Shokouh-Amiri MH, Egidi MF, Grewal HP, Lo A, Kizilisik AT, Nezakatgoo N, Gaber LW, Gaber AO. Long-term experience with simultaneous kidney-pancreas transplantation with portal-enteric drainage and tacrolimus/mycophenolate mofetil-based immunosuppression. Clin Transplant 2003. 17(Suppl 9):69-77.
  6. Gonin JM. Maintenance immunosuppression: new agents and persistent dilemmas. Adv Ren Replace Ther 2000. 7:95-116.
  7. Kasiske BL, Snyder JJ, Matas AJ, Ellison MD, Gill JS, Kausz AT. Preemptive kidney transplantation: the advantage and the advantaged. J Am Soc Nephrol 2002. 13:1358-1364.
  8. Hricik DE. Steroid withdrawal in renal transplant recipients: pro point of view. Transplant Proc 1998. 30:1380-1382.
  9. Jordan ML, Chakrabarti P, Luke P, Shapiro R, Vivas CA, Scantlebury VP, Fung JJ, Starzl TE, Corry RJ. Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression. Transplantation 2000. 69:265-271.
  10. Humar A, Parr E, Drangstveit MB, Kandaswamy R, Gruessner AC, Sutherland DE. Steroid withdrawal in pancreas transplant recipients. Clin Transplant 2000. 14:75-78.
  11. Jindel RM, Joseph JT, Morris MC, Santella RN, Baines LS. Noncompliance after kidney transplantation: a systematic review. Transplant Proc 2003. 35:2868-2872.
  12. Kaufman DB, Shapiro R, Lucey MR, Cherikh WS, T Bustami R, Dyke DB. Immunosuppression: practice and trends. Am J Transplant 2004. 4(Suppl 9):38-53.
  13. Bassetti M, Salvalaggio PR, Topal J, Lorber MI, Friedman AL, Andriole VT, Basadonna GP. Incidence, timing and site of infections among pancreas transplant recipients. J Hosp Infect. 2004. 56:184-190.


 
Respond on this Journal Article!
Hint: Your Response should directly apply to Tailored Immunosuppression and Steroid Withdrawal in Pancreas-Kidney Transplantation. Please check, if this context applies best to your contribution. Otherwise click HERE to change to the appropriate subject area. The actual subject area is Kidney-Pancreas Transplantation.